InvestorsHub Logo
Followers 80
Posts 24702
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 10/20/2017 8:31:33 AM

Friday, October 20, 2017 8:31:33 AM

Post# of 27621
ACRX - 1.75 Pre-market now at 1.85/1.90

AcelRx's DSUVIA™ Clinical Trial Results Selected as a "Top Abstract" for Oral Presentation at ASA's Annual Meeting - ANESTHESIOLOGY® 2017



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.